News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates     8/22/2017
Sarepta (SRPT)’s Exondys 51 Saga Continues as More Details About FDA’s Criticism Uncovered     8/22/2017
AstraZeneca PLC (AZN) Jumps Deeper Into mRNA Drugs With Ethris Deal     8/21/2017
FDA Green Lights Pfizer (PFE) Drug for Rare, Fast-Killing Type of Leukemia     8/18/2017
Heads Up Tesaro (TSRO): AstraZeneca PLC (AZN), Merck & Co. (MRK)'s Ovarian Cancer Drug Just Got Expanded Use From the FDA     8/18/2017
This is What Happens When the FDA Approves Cancer Drugs Too Quickly     8/17/2017
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+     8/17/2017
Biogen (BIIB) Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech     8/17/2017
Novo Nordisk A/S (NVO)’s Diabetes Drug Beats Out Eli Lilly (LLY)’s Trulicity in Phase III Trials     8/17/2017
Bristol-Myers Squibb (BMY)'s Stock Topples as Kidney Cancer Drug Flunks Phase III Study     8/16/2017
As Its CEO Retires, Cerecor (CERC) Divests Depression Drug to Pharma Giant in $45 Million Deal     8/15/2017
Ophthotech (OPHT)'s Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study     8/15/2017
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma     8/15/2017
Galapagos (GLPG.BR)' Phase II Results With GLPG1690 are 'Extremely Exciting'     8/14/2017
Takeda (TKPYY) Teams Up With Marvel Comics on Inflammatory Bowel Disease Graphic Novel     8/11/2017

News from Around the Web
Their Genes Put Them At High Risk Of Alzheimer’s. So They’re Experimenting — On Themselves     8/22/2017
Tool IDs Diabetes Patients At Risk For Severe Hypoglycemia, Kaiser Permanente Study     8/22/2017
FDA Confirms Becton, Dickinson and Company (BDX) Blood Tubes Not Linked to Inaccurate Lead Results     8/18/2017
Disappointment Over Bristol-Myers Squibb (BMY)'s Kidney Combo Boosts Bay Area's Exelixis (EXEL)     8/17/2017
Cook Medical Recalls Select Zenith Alpha Thoracic Endovascular Grafts     8/17/2017
Fake Painkillers Laced With A Legal Drug 50 Times Stronger Than Heroin     8/16/2017
A New Heart Disease Test Flings Color Genomics Into A Battle About Genetics In Medicine     8/11/2017
How AI Robots Hunt New Drugs For Crippling Nerve Disease     8/10/2017
For Vertex (VRTX), Can One Billion-Dollar Breakthrough Beget Another?     8/9/2017
Does Roche (RHHBY) Have The Hemophilia X Factor?     8/9/2017
New OCT Technique Provides Better 3-D Imaging Of The Cellular Structure Of The Eye, Medical University of Vienna Study     8/8/2017
AbbVie (ABBV)’s New, Cheaper Hepatitis C Drug Could Launch The Drug World’s Own Hunger Games     8/7/2017
Here's Why Silicon Valley Will Be Full Of Beautiful People In 2040     8/4/2017
Roche (RHHBY)’s Tecentriq Hits Trouble with NICE in Bladder Cancer     8/3/2017
Why We Can’t Have the Male Pill     8/3/2017

Press Releases
Apic Bio Launches To Advance First-In-Class Gene Therapy For Treatment Of Alpha-1 Antitrypsin Deficiency (Alpha 1)     8/22/2017
BESPONSA (Inotuzumab Ozogamicin) Approved For Treatment Of Adult Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia, Available For Order At Biologics     8/22/2017
Octapharma USA Announces FDA Approval Of NUWIQ New Product Strengths, Expanding Hemophilia A Patient Treatment Options     8/22/2017
Astellas (ALPMY) Release:First Patient Dosed In Phase III MORPHO Trial Evaluating Gilteritinib As Maintenance Therapy Following Hematopoietic Stem Cell Transplant In Patients With FLT3 Mutation-Positive Acute Myeloid Leukemia     8/22/2017
Alliance Foundation Trials Opens Global Trial Investigating First-In-Class Palbociclib In HR+, HER2+ Metastatic Breast Cancer     8/22/2017
Phase I Trials For Two Novel Treatments Of Obesity And/Or Diabetes Initiated By Zealand Pharma  (ZEAL.CO) Partner Boehringer Ingelheim     8/22/2017
Novartis AG (NVS) Launches First Large-Scale Research Study In Multiple Sclerosis That Allows Participants To Contribute From Smartphones     8/22/2017
Grid Therapeutics Signs Exclusive License Agreement To Develop A Novel Immuno-Oncology Antibody     8/22/2017
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Out-Licensing Of DFD-06 To Encore Dermatology     8/22/2017
Cellerant Therapeutics, Inc. Awarded $6.86 Million Grant From California Institute For Regenerative Medicine To Support Development Of Novel Antibody-Drug Conjugate For AML     8/22/2017
Uptake Of Sanofi (SNY)/Regeneron (REGN)'s Dupixent For Atopic Dermatitis Strong, But Sales Representative Contact Rates Leave Something To Be Desired     8/22/2017
Malin (MLC.IR) Snags FDA Approval for New Hourglass Peripheral Embolisation Plug     8/22/2017
DexCom (DXCM) Release: New Study Shows People With Type 2 Diabetes Benefit From Continuous Glucose Monitoring     8/22/2017
Life Spine Announces First Cases Performed With Multiple Methods Of In-Situ Expansion     8/22/2017
QIAGEN N.V. (QGEN) And Clinical Genomics Pty Ltd Partner On Liquid Biopsies To Monitor Patients For Recurrence Of Colorectal Cancer     8/22/2017

//-->